IDEX (IEX) News Today

IDEX Corporation (NYSE:IEX) shares are reacting to a mix of analyst forecast revisions from Zacks Research—upgrades to some future quarters partly offset by cuts elsewhere—and heightened attention on a separate IDEX‐branded company’s financing. These developments are driving trading interest in IEX today.

• Positive Sentiment: Zacks Research raised its Q2 2027 EPS forecast for IEX to $2.51 from $2.45.
• Positive Sentiment: Zacks Research bumped up its Q1 2026 EPS estimate to $1.87 from $1.86.
• Positive Sentiment: Zacks Research lifted its FY 2027 EPS projection to $9.46 from $9.44.
• Neutral Sentiment: IDEX Biometrics ASA (OTC:IDXAF) completed the second tranche of a private placement, strengthening its leadership stake—though this pertains to a separate entity. Article Title
• Negative Sentiment: Zacks Research trimmed its Q4 2026 EPS estimate to $2.19 from $2.27.
• Negative Sentiment: Zacks Research cut its Q3 2026 EPS forecast to $2.15 from $2.23.
• Negative Sentiment: Zacks Research reduced its Q2 2026 EPS estimate to $2.24 from $2.27.
• Negative Sentiment: Zacks Research lowered its Q4 2025 EPS projection to $2.15 from $2.33.
• Negative Sentiment: Zacks Research slashed its Q3 2025 EPS estimate to $1.93 from $2.18.
• Negative Sentiment: Zacks Research cut its FY 2025 EPS forecast to $7.90 from $8.28.